Short Interest in Innovator IBD 50 ETF (NYSEARCA:FFTY) Expands By 169.8%

Innovator IBD 50 ETF (NYSEARCA:FFTY) was the recipient of a large increase in short interest in the month of August. As of August 31st, there was short interest totaling 31,675 shares, an increase of 169.8% from the August 15th total of 11,741 shares. Based on an average daily volume of 17,743 shares, the short-interest ratio is presently 1.8 days. Currently, 1.5% of the shares of the company are sold short.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the business. AlphaCore Capital LLC acquired a new stake in Innovator IBD 50 ETF in the 4th quarter valued at $32,000. International Assets Investment Management LLC acquired a new position in Innovator IBD 50 ETF during the fourth quarter worth $35,000. Simplex Trading LLC purchased a new position in Innovator IBD 50 ETF during the fourth quarter valued at $41,000. Advisory Services Network LLC purchased a new position in Innovator IBD 50 ETF during the third quarter valued at $43,000. Finally, Kestra Advisory Services LLC acquired a new stake in shares of Innovator IBD 50 ETF in the fourth quarter valued at about $72,000.

Innovator IBD 50 ETF Stock Performance

Shares of NYSEARCA FFTY opened at $35.24 on Friday. The company’s fifty day moving average price is $37.51 and its 200 day moving average price is $38.31. Innovator IBD 50 ETF has a 1 year low of $31.61 and a 1 year high of $44.08. The company has a market capitalization of $75.77 million, a PE ratio of 30.34 and a beta of 1.45.

About Innovator IBD 50 ETF

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.